Home
Conditions
Stage IV Renal Cell Cancer AJCC v8

Clinical trial condition

Stage IV Renal Cell Cancer AJCC v8

Explore clinical trials studying Stage IV Renal Cell Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

50 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Renal Cell Cancer AJCC v8 trial results

Recruiting

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

NCT07128680

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, +20 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Medical Center Irvine, California, United States

View Trial Details

Recruiting

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

NCT07405086

Conditions: Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +63 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

NCT07383441

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations: Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

Highlands Oncology Group - Rogers Rogers, Arkansas, United States

Highlands Oncology Group Springdale, Arkansas, United States

View all 41 locations

View Trial Details

Recruiting

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

NCT06265285

Conditions: Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

NCT07037004

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Recruiting

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

NCT07510334

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

NCT04693377

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +66 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

NCT06349642

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
Locations: Mayo Clinic in Arizona Phoenix, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

NCT04510597

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Kingman Regional Medical Center Kingman, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 387 locations

View Trial Details

Recruiting

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

NCT06399419

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +22 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Stage IV Renal Cell Cancer AJCC v8

Stage IV Renal Cell Cancer AJCC v8 trial results

Related conditions